The University of Chicago Header Logo
Last Name

Marcia Tan

TitleAssistant Professor
InstitutionUniversity of Chicago
DepartmentPublic Health Sciences
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. Tan is a health psychologist and epidemiologist who focuses on reducing health disparities among underserved populations through health behavior change. Her research interests are 1) examining biopsychosocial and behavioral factors that contribute to disparities in chronic disease, primarily cancer, and 2) conducting community-based health behavior interventions to reduce risk factors among disparity populations. A majority of her work has focused on tobacco cessation and weight management among low-income and racial/ethnic minority populations.

    Collapse Biography 
    Collapse education and training
    Northwestern University Feinberg School of Medicine, Chicago, ILPostdoctoral Fellowship08/2018Cancer Prevention
    University of Miami, Miami, FLPhD08/2016Clinical Health Psychology
    Miami VA Medical Center, Miami, FLPredoctoral Clinical Internship07/2016Health Psychology
    Emory University Rollins School of Public Health, Atlanta, GAMPH05/2010Epidemiology
    University of Alabama, Tuscaloosa, ALBS05/2007Psychology

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Jao NC, Tan MM, Matthews PA, Simon MA, Schnoll R, Hitsman B. Menthol cigarettes, tobacco dependence, and smoking persistence: The need to examine enhanced cognitive functioning as a neuropsychological mechanism. Nicotine Tob Res. 2018 Dec 14. PMID: 30551213.
      View in: PubMed
    2. Bush T, Lovejoy J, Javitz H, Torres AJ, Wassum K, Tan MM, Spring B. Simultaneous vs. sequential treatment for smoking and weight management in tobacco quitlines: 6 and 12 month outcomes from a randomized trial. BMC Public Health. 2018 05 31; 18(1):678. PMID: 29855294.
      View in: PubMed
    3. Tan MM, Okuyemi KS, Resnicow K, Dietz NA, Antoni MH, Webb Hooper M. Association between smoking cessation and weight gain in treatment-seeking African Americans. Addict Behav. 2018 06; 81:84-90. PMID: 29452980.
      View in: PubMed
    4. Rodríguez Esquivel D, Webb Hooper M, Baker EA, McNutt MD. Culturally specific versus standard smoking cessation messages targeting Hispanics: An experiment. Psychol Addict Behav. 2015 Jun; 29(2):283-9. PMID: 26076096.
      View in: PubMed
    5. Webb Hooper, M, McNutt, MD, Baker, EA. Psychosocial correlates of perceived stress and depressive symptoms among help-seeking Hispanic smokers. Journal of Health Disparities Research and Practice. 2015; 8(2):106-117.
    6. Musselman DL, Ziemer DC, McNutt MD, Seay JS, Royster EB, Larsen B, Barham T, Brown AR, Vogel OL, Phillips LS, Harvey PD. Depression, deficits in functional capacity, and impaired glycemic control in urban African Americans with type 2 diabetes. J Psychiatr Res. 2014 May; 52:21-7. PMID: 24491959.
      View in: PubMed
    7. Webb Hooper M, Baker EA, McNutt MD. Racial/Ethnic differences among smokers: revisited and expanded to help seekers. Nicotine Tob Res. 2014 May; 16(5):621-5. PMID: 24336396.
      View in: PubMed
    8. Webb Hooper M, Baker EA, McNutt MD. Associations between coping, affect, and social support among low-income African American smokers. Addict Behav. 2013 Nov; 38(11):2736-40. PMID: 23934005.
      View in: PubMed
    9. Musselman D, Royster EB, Wang M, Long Q, Trimble LM, Mann TK, Graciaa DS, McNutt MD, Auyeung NS, Oliver L, Lawson DH, Miller AH. The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings. Neuropsychopharmacology. 2013 Sep; 38(10):1921-8. PMID: 23575741.
      View in: PubMed
    10. McNutt MD, Liu S, Manatunga A, Royster EB, Raison CL, Woolwine BJ, Demetrashvili MF, Miller AH, Musselman DL. Neurobehavioral effects of interferon-a in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine. Neuropsychopharmacology. 2012 May; 37(6):1444-54. PMID: 22353759.
      View in: PubMed
    11. Webb Hooper, M, Baker, EA, Rodriguez de Ybarra, D, McNutt, M, & Ahluwalia, JS . Acculturation predicts 7-day smoking cessation among treatment-seeking African -Americans in a group intervention. Annals of Behavioral Medicine. 2012; 43(1):74-83.
    12. McNutt, MD, Webb Hooper, M. In M Gellman and JR Turner (Eds.) Encyclopedia of Behavioral Medicine. Ex-smokers. 2012; 741-42.
    13. Larsen HH, Ritchie JC, McNutt MD, Musselman DL. Pulmonary embolism in a patient with catatonia: an old disease, changing times. Psychosomatics. 2011 Jul-Aug; 52(4):387-91. PMID: 21777724.
      View in: PubMed
    14. Musselman, DL, Miller, AH, Royster, EB, McNutt, MD. In DW Kissane, M Maj, and N Sartorius (Eds.) Depression and Cancer. Biology of depression and cytokines in cancer. 2011; 51-80.
    15. Auyeung SF, Long Q, Royster EB, Murthy S, McNutt MD, Lawson D, Miller A, Manatunga A, Musselman DL. Sequential multiple-assignment randomized trial design of neurobehavioral treatment for patients with metastatic malignant melanoma undergoing high-dose interferon-alpha therapy. Clin Trials. 2009 Oct; 6(5):480-90. PMID: 19786415.
      View in: PubMed
    Tan's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Similar People Expand Description
    Same Department Expand Description
    Physical Neighbors Expand Description